Company snapshot
- Ticker
- VRTX
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $140.2B
- Employees
- 6,400
- Currency
- USD
- Website
- https://www.vrtx.com
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del…
Latest coverage
- Casgevy Starts Paying Off for CRISPR: Rapid Earnings Reaction
November 2, 2026